Differential Effects of Alzheimer's Disease Aβ40 and 42 on Endocytosis and Intraneuronal Trafficking.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Neuroscience

• Publication date

  2018-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.neuroscience.2018.01.003PMID 29337241
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amyloid-Beta Induced Changes in Vesicular Transport of BDNF in Hippocampal Neurons

  2016cited by this paper
• Amyloid β oligomers elicit mitochondrial transport defects and fragmentation in a time-dependent and pathway-specific manner

  2016cited by this paper
• Central role for PICALM in amyloid–β blood–brain barrier transcytosis and clearance

  2015cited by this paper
• Intracellular amyloid β oligomers impair organelle transport and induce dendritic spine loss in primary neurons

  2015cited by this paper
• Rab7 Is Functionally Required for Selective Cargo Sorting at the Early Endosome

  2014cited by this paper
• Neuronal signaling through endocytosis.

  2014cited by this paper
• Trafficking regulation of proteins in Alzheimer’s disease

  2014cited by this paper
• Deleterious effects of soluble amyloid-β oligomers on multiple steps of synaptic vesicle trafficking.

  2013cited by this paper
• Human LilrB2 Is a β-Amyloid Receptor and Its Murine Homolog PirB Regulates Synaptic Plasticity in an Alzheimer’s Model

  2013cited by this paper
• Differential Regulation of Amyloid-β Endocytic Trafficking and Lysosomal Degradation by Apolipoprotein E Isoforms*♦

  2012cited by this paper
• Differences in the cellular uptake and intracellular itineraries of amyloid beta proteins 40 and 42: ramifications for the Alzheimer's drug discovery.

  2012cited by this paper
• Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.

  2012cited by this paper
• Functional Links Between Aβ Toxicity, Endocytic Trafficking, and Alzheimer’s Disease Risk Factors in Yeast

  2011cited by this paper
• Molecular mechanism and physiological functions of clathrin-mediated endocytosis

  2011cited by this paper
• An In Vitro Model for Neuroscience: Differentiation of SH-SY5Y Cells into Cells with Morphological and Biochemical Characteristics of Mature Neurons

  2010cited by this paper
• Cellular Prion Protein Mediates Impairment of Synaptic Plasticity by Amyloid-β Oligomers

  2009cited by this paper
• Amyloid β Protein: Aβ40 Inhibits Aβ42 Oligomerization

  2009cited by this paper
• Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide

  2009cited by this paper
• Mechanism of Neuronal versus Endothelial Cell Uptake of Alzheimer's Disease Amyloid β Protein

  2009cited by this paper
• Evidence for CALM in Directing VAMP2 Trafficking

  2008cited by this paper
• Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons

  2008cited by this paper
• GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor

  2007cited by this paper
• Intracellular amyloid-β in Alzheimer's disease

  2007cited by this paper
• Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy

  2007cited by this paper
• Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain.

  2007cited by this paper
• Abeta40 protects non-toxic Abeta42 monomer from aggregation.

  2007cited by this paper
• Intracellular amyloid-beta in Alzheimer's disease.

  2007cited by this paper
• Aβ40 Protects Non-toxic Aβ42 Monomer from Aggregation

  2007cited by this paper
• Distinct Endocytic Mechanisms of CD22 (Siglec-2) and Siglec-F Reflect Roles in Cell Signaling and Innate Immunity

  2007cited by this paper
• Physiological and Biophysical Factors That Influence Alzheimer's Disease Amyloid Plaque Targeting of Native and Putrescine Modified Human Amyloid β40

  2006cited by this paper
• limma: Linear Models for Microarray Data

  2005cited by this paper
• The c‐Cbl/CD2AP complex regulates VEGF‐induced endocytosis and degradation of Flt‐1 (VEGFR‐1)

  2004cited by this paper
• Synaptic frailty and clathrin-mediated synaptic vesicle trafficking in Alzheimer's disease.

  2004cited by this paper
• A modified β‐amyloid hypothesis: intraneuronal accumulation of the β‐amyloid peptide – the first step of a fatal cascade

  2004cited by this paper
• Amyloid β‐protein (Aβ)1–40 protects neurons from damage induced by Aβ1–42 in culture and in rat brain

  2003cited by this paper
• Amyloid beta-protein (Abeta)1-40 protects neurons from damage induced by Abeta1-42 in culture and in rat brain.

  2003cited by this paper
• Rab5-stimulated Up-regulation of the Endocytic Pathway Increases Intracellular β-Cleaved Amyloid Precursor Protein Carboxyl-terminal Fragment Levels and Aβ Production*

  2003cited by this paper
• Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets.

  2002cited by this paper
• The neuronal endosomal-lysosomal system in Alzheimer's disease

  2001cited by this paper
• Increased Neuronal Endocytosis and Protease Delivery to Early Endosomes in Sporadic Alzheimer’s Disease: Neuropathologic Evidence for a Mechanism of Increased β-Amyloidogenesis

  1997cited by this paper
• Amphiphysin heterodimers: potential role in clathrin-mediated endocytosis.

  1997cited by this paper
• The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family.

  1996cited by this paper
• Amyloid beta oligomers elicit mitochondrial transport defects and fragmentation in a time-dependent and pathway-specific manner

  year unknowncited by this paper

• Amyloid beta peptides inhibit glucose transport at the blood-brain barrier by disrupting the insulin-AKT pathway

  2025cites this paper
• The CHD family chromatin remodeling enzyme, Kismet, promotes both clathrin-mediated and activity-dependent bulk endocytosis

  2024cites this paper
• Tracking mitochondrial Cu(I) fluctuations through a ratiometric fluorescent probe in AD model cells: Towards understanding how AβOs induce mitochondrial Cu(I) dyshomeostasis.

  2024cites this paper
• Electrostatic assembly of gold nanoparticle and metal-organic framework nanoparticles attenuates amyloid β aggregate-mediated neurotoxicity.

  2023cites this paper
• Amyloid-Beta Peptides 40 and 42 Employ Distinct Molecular Pathways for Cell Entry and Intracellular Transit at the Blood–Brain Barrier Endothelium

  2023cites this paper
• Upregulation of endocytic protein expression in the Alzheimer’s disease male human brain

  2023cites this paper
• Amyloid-beta peptides 40 and 42 employ distinct molecular pathways for cell entry and intracellular transit at the BBB endothelium

  2022cites this paper
• Protect Effects of Seafood-Derived Plasmalogens Against Amyloid-Beta (1–42) Induced Toxicity via Modulating the Transcripts Related to Endocytosis, Autophagy, Apoptosis, Neurotransmitter Release and Synaptic Transmission in SH-SY5Y Cells

  2021cites this paper
• Left Ventricular Ejection Fraction and Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease Pathology in Cognitively Normal Older Adults: The CABLE Study

  2021cites this paper
• Amyloid-β Peptides Disrupt Interactions Between VAMP-2 and SNAP-25 in Neuronal Cells as Determined by FRET/FLIM

  2020cites this paper
• Evidence that Brain-Reactive Autoantibodies Contribute to Chronic Neuronal Internalization of Exogenous Amyloid-β1-42 and Key Cell Surface Proteins During Alzheimer’s Disease Pathogenesis

  2020cites this paper
• Amyloid-beta impairs TOM1-mediated IL-1R1 signaling

  2019cites this paper
• Nanoparticle-conjugated nutraceuticals exert prospectively palliative of amyloid aggregation

  2018cites this paper